Turnkey, high-end life sciences space remains in high demand in New Jersey, creating an opportunity for owners of the state’s few remaining legacy pharmaceutical campuses or those that can find other ways to create new space without building speculatively.
Accurate’s pipeline is surging, with an aggressive (but long-term) approach to development
Accurate has been prolific in building and lining up new multifamily development projects across New Jersey, having completed some 1,000 residential units since 2021 alone. It now has construction underway, approvals in place or sites under control to build another roughly 6,400 apartments and townhomes, including some 4,000 in Newark, with more to come.